-
Meridian Bioscience receives FDA approval for Shiga-detecting test
Rapid diagnostic tool is first to distinguish between Shiga toxin producing E. coli and other 0157 strains; partnership with Merck pays off; only twenty minures needed to make a diagnosis
-
-
Scripps researchers identify botulism-fighting molecules
One compound extends survival time by thirty-six percent; sixteen percent of mice treated with the second molecule survived with no obvious symptoms
-
-
University of Portsmouth to test antibacterial gown
Hospital garb is coated with an anti-microbial coating known as Permagard; effort intended to mitigate MRSA transmission; unique design also minimizes contact with nurses
-
-
FluMist found to reduce childhood infections by 55 percent
Report comes soon after FDA approves Medimmune’s refrigerated vaccine; heightened asthma risks for infants cited; company looks poised to run away with the novel flu vaccine market, especially if deal with Iomai goes through
-
-
Air Force deploys mobile bioweapons detection labs
Equipped with $100,000 in equipment, the trailer can quickly identify fourteen biological agents; McConnell Air Force Base plays host; mobile testing marches on
-
-
DHS to consolidate Centers of Excellence program
Three centers focussing on biological and chemical weapons will merge; four new centers to come on line; decision prompted by congressional criticism and threatened budget cuts
-
-
Arkansas researchers develop new avian flu sensor
Swab samples from birds’ throats are exposed to micofluidic biochips; resulting complex is measured with a microelectrode array; researchers currently looking for funding
-
-
Universal Detection receives Army anthrax detection order
Early warning BSM-2000 anthrax kits will be tested at the Dugway Proving Ground; the British government has already purchased two, but deal is the first with DoD; systems “pops” spores to measure the release of dipicolinic acid
-
-
Nunn-Lugar appropriations come under fire
Senator Lugar slams the administration for cutting the overall budget by 7 percent and shortchanging efforts to secure biological weapons in the former Soviet Union; projects in Ukraine and Armenia to be delayed under proposd budget; Lugar will attempt to reinstate funding
-
-
Polonium poisoning creates a market need for treatment
Few treatments exists for curing alpha particle damage; Litvinenko’s death sends companies scrambling; Ovation Pharmaceuticals, Biolabs Protectan, and Hollis-Eden Pharmaceuticals all make claims
-
-
Washington U. researchers discover plague's weakness
The scourge of the Middle Ages continues to plague Africa; terrorism another major fear; researchers disable Yersinia pestis by removing a clot-inhibiting protein
-
-
Iomai wins $128 million HHS contract for patch-based flu vaccine
Innoculation method could be mailed to patients; adjuvant stimulants allow the company to stretch out the nation’s vaccine supply; company looks for distribution partners, but many already see MedImmune as the most promising candidate
-
-
Massachusetts researchers add nanotransmitters to microfluidic arrays
Technique used to quickly identify pathogens such as anthrax; cuts down on the size of handheld and static detection devices; waveguide and nanoantennas focus light to a spot size smaller than half its wavelength
-
-
Biophotonics market to emerge in 2011
Experts predict a $2 billion industry in a few years; intrinisc and extrinsic sensors try to prove themselves in the drug industry but with limited success; breakthroughs needed in microarrays before major homeland security applications will be possible
-
-
Raman spectroscopy used to identify counterfeit drugs
Breakthrough approach can identify fakes while inside their packaging; researchers at the Rutherford Appleton Laboratory adjust the collection point a few millimeters in front of the laser signal; tests on paracetamol and ibuprofen prove the concept
-
More headlines
The long view
Global Anxiety and the Security Dimension: From Personal Despair to Political Violence
Uncertainty and despair—born of economic insecurity, social isolation, and widening inequality—have fueled a striking surge in anxiety across the United States. But this mental-health crisis is not confined by borders.
The Silent Epidemic: America’s Growing Anxiety Crisis
Anxiety—once dismissed as mere nerves or a passing phase—has become one of the most prevalent and debilitating public health issues facing Americans today. how did we get here—and what do we do now?